Cavium, Inc. (CAVM) stock slides, “Hold” rating reaffirmed by Canaccord Genuity Analysts

Cavium, Inc. (NASDAQ: CAVM) shares fell on Tuesday January 31 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, The Dow Jones Industrial Average DJIA, -0.60% fell 140 points, or 0.7%, to 19,833, with 26 of the 30 blue-chip companies trading lower. Nike, Inc. NKE, -1.10% down 2.4% and Intel Corp. INTC, -1.70% off 1%, were leading losses.

The S&P 500 SPX, -0.33% was off by 10 points, or 0.5%, to 2,270 with seven of the 11 main sectors trading lower. Industrials, consumer-discretionary, and technology shares were the worst performers, while real estate and utilities stocks attracted buyers.

The health-care sector, which was down in early trade, rebounded after President Trump called for scaling back drugmaker’s regulation, lowering taxes and prices of medicines.

The Nasdaq Composite COMP, -0.25% declined 31 points, or 0.6%, to 5,581.

Analysts at Canaccord Genuity reiterated a Hold rating on shares of Cavium, Inc. (NASDAQ: CAVM) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. With a rating of Hold on the shares, the company has a 52-week high of $66.42. The one-year price target of $66.00 is above the opening price of $65.91, resulting a fair amount of other analysts to issue statements on the company recently. Share prices sometimes get a bounce to the upside when analysts reiterate coverage.

Shares of Cavium, Inc. (NASDAQ: CAVM) opened at $65.91 yesterday trading between $64.90 and $65.91, and last traded at $65.28, a drop of $0.87 from the previous closing price.

Cavium, Inc. (NASDAQ: CAVM) now has a market cap of 4.37B.

Cavium, Inc. (NASDAQ: CAVM) Average Daily Trading Volume

The stock’s average daily volume is 995,990 shares out of a total float 64,768,000 and some 79,980 shares traded hands yesterday, 30 percent lower than the average. lower than normal. Look for trading volume to pick up in the coming days as swing traders often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for short periods will not mean much will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these have teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

Cavium, Inc. (NASDAQ: CAVM) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, Cavium, Inc. (NASDAQ: CAVM) now has a 50-day MA of $63.46 and 200-day MA of $56.13. It has traded in a 52-week range between $35.90 – 66.42 and today’s last price is 1.72%% lower than the 52 week high of $66.42.

Earnings growth is a critical factor to look at when investing in stocks and investors seek companies that have been successful at growing their earnings by at least 25% over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *